Skip to main content

Decoy Therapeutics

Cambridge, United States

Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.

$3.5M raised
Jun 2026
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Decoy Therapeutics

How much funding has Decoy Therapeutics raised?
Decoy Therapeutics has raised $3.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Who are Decoy Therapeutics's investors?
Decoy Therapeutics's investors include Massachusetts Life Sciences Center.
Where is Decoy Therapeutics headquartered?
Decoy Therapeutics is headquartered in Cambridge, United States.
What does Decoy Therapeutics do?
Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.
What stage is Decoy Therapeutics at?
Decoy Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Decoy Therapeutics — Funding & Investors." VCBacked, June 26, 2026, https://www.vcbacked.co/company/decoy-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2026). Decoy Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/decoy-therapeutics
Wikipedia (cite web)
{{cite web |title=Decoy Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/decoy-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .